Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Gagne

Showing results (81-90 of 344) with videos related to

Pageof 35
Sort By:
Pharmacotherapy|October 14, 2017
Comparison of Treatment Persistence with Dabigatran or Rivaroxaban versus Vitamin K Antagonist Oral Anticoagulants in Atrial Fibrillation Patients: A Competing Risk Analysis in the French National Health Care DatabasesGéric Maura, Cécile Billionnet, François Alla, et al.
JAMA|May 5, 2011
Availability of comparative efficacy data at the time of drug approval in the United StatesNikolas H Goldberg, Sebastian Schneeweiss, Mary K Kowal, et al.
Journal of Clinical Epidemiology|January 7, 2011
A combined comorbidity score predicted mortality in elderly patients better than existing scoresJoshua J Gagne, Robert J Glynn, Jerry Avorn, et al.
Emerging Themes in Epidemiology|April 8, 2016
Dimension reduction and shrinkage methods for high dimensional disease risk scores in historical dataHiraku Kumamaru, Sebastian Schneeweiss, Robert J Glynn, et al.
Cardiovascular and Interventional Radiology|February 5, 2000
Isolation of the left innominate artery in an elderly patient without congenital heart diseaseE L Boren, W J Matchett, P J Gagne, et al.
Journal of Clinical Pharmacy and Therapeutics|October 10, 2013
Risk of death associated with the use of conventional vs. atypical antipsychotic medications: evaluating the use of the Emilia-Romagna Region database for pharmacoepidemiological studiesS Sikirica, M Marino, J J Gagne, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|April 25, 2020
Using Data From Routine Care to Estimate the Effectiveness and Potential Limitations of Outcomes-Based Contracts for Diabetes MedicationsMichael Fralick, Joshua J Gagne, Elisabetta Patorno, et al.
The Patient|September 23, 2018
General Population vs. Patient Preferences in Anticoagulant Therapy: A Discrete Choice ExperimentMehdi Najafzadeh, Sebastian Schneeweiss, Niteesh K Choudhry, et al.
The Patient|November 3, 2014
Development and use of new therapeutics for rare diseases: views from patients, caregivers, and advocatesAaron S Kesselheim, Sarah McGraw, Lauren Thompson, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|June 13, 2021
Factors Associated With Generic Drug Uptake in the United States, 2012 to 2017Benjamin N Rome, ChangWon C Lee, Joshua J Gagne, et al.
Pageof 35

Showing results (81-90 of 344) with videos related to

Sort By:
Pageof 35
Pharmacotherapy|October 14, 2017
Comparison of Treatment Persistence with Dabigatran or Rivaroxaban versus Vitamin K Antagonist Oral Anticoagulants in Atrial Fibrillation Patients: A Competing Risk Analysis in the French National Health Care DatabasesGéric Maura, Cécile Billionnet, François Alla, et al.
JAMA|May 5, 2011
Availability of comparative efficacy data at the time of drug approval in the United StatesNikolas H Goldberg, Sebastian Schneeweiss, Mary K Kowal, et al.
Journal of Clinical Epidemiology|January 7, 2011
A combined comorbidity score predicted mortality in elderly patients better than existing scoresJoshua J Gagne, Robert J Glynn, Jerry Avorn, et al.
Emerging Themes in Epidemiology|April 8, 2016
Dimension reduction and shrinkage methods for high dimensional disease risk scores in historical dataHiraku Kumamaru, Sebastian Schneeweiss, Robert J Glynn, et al.
Cardiovascular and Interventional Radiology|February 5, 2000
Isolation of the left innominate artery in an elderly patient without congenital heart diseaseE L Boren, W J Matchett, P J Gagne, et al.
Journal of Clinical Pharmacy and Therapeutics|October 10, 2013
Risk of death associated with the use of conventional vs. atypical antipsychotic medications: evaluating the use of the Emilia-Romagna Region database for pharmacoepidemiological studiesS Sikirica, M Marino, J J Gagne, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|April 25, 2020
Using Data From Routine Care to Estimate the Effectiveness and Potential Limitations of Outcomes-Based Contracts for Diabetes MedicationsMichael Fralick, Joshua J Gagne, Elisabetta Patorno, et al.
The Patient|September 23, 2018
General Population vs. Patient Preferences in Anticoagulant Therapy: A Discrete Choice ExperimentMehdi Najafzadeh, Sebastian Schneeweiss, Niteesh K Choudhry, et al.
The Patient|November 3, 2014
Development and use of new therapeutics for rare diseases: views from patients, caregivers, and advocatesAaron S Kesselheim, Sarah McGraw, Lauren Thompson, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|June 13, 2021
Factors Associated With Generic Drug Uptake in the United States, 2012 to 2017Benjamin N Rome, ChangWon C Lee, Joshua J Gagne, et al.
Pageof 35